Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 3, Issue 3 , Pages 177-179, July 2007

Commentary on “Health economics and the value of therapy in Alzheimer’s disease.” Cholinesterase inhibitors in Alzheimer’s disease—Evidence-based or evidence-biased?

Psychopharmacology Research Program and Department of Psychiatry, Sunnybrook Health Sciences Center; and Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1552-5260(07)00485-2

doi:10.1016/j.jalz.2007.04.389

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 3, Issue 3 , Pages 177-179, July 2007

Article Tools